Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Berruezo Llacuna, Maria (1) Blankenstein, Thomas Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Filosa, Alessandro Dr. (1) Graf, Robin Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Jeuthe, Sarah Dr. (1) Kammertöns, Thomas Dr. (3) Keller, Lisa (1) Keller, Ulrich Dr. med. (2) Kocks, Christine Dr. (1) Leutz, Achim Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (6) Mertins, Philipp Dr. (1) Popp, Oliver Dr. (1) Prigione, Alessandro Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Sawamiphak, Suphansa Dr. (1) Uckert, Wolfgang Prof. Dr. (1) (-) Janz, Martin Dr. (8) (-) Leisegang, Matthias Prof. Dr. rer. nat. (2) (-) Wollert-Wulf, Brigitte (2) Bioinformatics and Omics Data Science (1) Bioinformatik der Genregulation (1) (-) Biologie maligner Lymphome (8) Epigenetische Modifikationen in Neuroblastom (3) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genomdiversifikation & Integrität (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Molekulare Herz- Kreislaufforschung (1) (-) Molekulare Immunologie und Gentherapie (2) Proteom Dynamik (8) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) RNA Biologie und Posttranscriptionale Regulation (1) Translational Bioinformatics (16) Translationale Tumorimmunologie (1) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (5) 2007 (2) 2008 (2) 2009 (3) 2010 (2) 2011 (5) 2012 (2) 2013 (2) 2014 (1) 2015 (4) 2016 (2) 2017 (4) 2018 (2) 2019 (3) (-) 2020 (5) 2021 (4) 2022 (7) 2023 (6) 2024 (1) 10 Ergebnisse: Active Filter: Janz, Martin Dr.Leisegang, Matthias Prof. Dr. rer. nat.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 20062020 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 20. Oktober 2020 / Proc Natl Acad Sci U S A The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions F. Scholz M. Grau L. Menzel A. Graband M. Zapukhlyak A. Leutz M. Janz G. Lenz A. Rehm U.E. Höpken 01. Oktober 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz 06. Juli 2020 / J Exp Med Restriction of memory B cell differentiation at the germinal center B cell positive selection stage A. Toboso-Navasa A. Gunawan G. Morlino R. Nakagawa A. Taddei D. Damry Y. Patel P. Chakravarty M. Janz G. Kassiotis R. Brink M. Eilers D.P. Calado 05. Oktober 2020 / J Exp Med PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification V. Delgado-Benito M. Berruezo-Llacuna R. Altwasser W. Winkler D. Sundaravinayagam S. Balasubramanian M. Caganova R. Graf A. Rahjouei M.T. Henke M. Driesner L. Keller A. Prigione M. Janz A. Akalin M. Di Virgilio 07. Februar 2020 / EMBO Mol Med "Designer cytokines" targeting the tumor vasculature - think global and act local T. Kammertoens J. Kemna M. Leisegang 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
20. Oktober 2020 / Proc Natl Acad Sci U S A The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions F. Scholz M. Grau L. Menzel A. Graband M. Zapukhlyak A. Leutz M. Janz G. Lenz A. Rehm U.E. Höpken
01. Oktober 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz
06. Juli 2020 / J Exp Med Restriction of memory B cell differentiation at the germinal center B cell positive selection stage A. Toboso-Navasa A. Gunawan G. Morlino R. Nakagawa A. Taddei D. Damry Y. Patel P. Chakravarty M. Janz G. Kassiotis R. Brink M. Eilers D.P. Calado
05. Oktober 2020 / J Exp Med PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification V. Delgado-Benito M. Berruezo-Llacuna R. Altwasser W. Winkler D. Sundaravinayagam S. Balasubramanian M. Caganova R. Graf A. Rahjouei M.T. Henke M. Driesner L. Keller A. Prigione M. Janz A. Akalin M. Di Virgilio
07. Februar 2020 / EMBO Mol Med "Designer cytokines" targeting the tumor vasculature - think global and act local T. Kammertoens J. Kemna M. Leisegang
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas